Effect of exogenous β-hydroxybutyrate on BDNF signaling, cognition, and amyloid precursor protein processing in humans with T2D and insulin-resistant rodents
Open Access
- 1 February 2025
- journal article
- Published by American Physiological Society in American Journal of Physiology-Cell Physiology
- Vol. 328 (2) , C541-C556
Abstract
Ketone supplementation does not alter circulating BDNF levels or cognition in humans with T2D. Acute and chronic ketone supplementation in C57BL/6J mice did not change BDNF protein content or improve recognition memory. Ketone supplementation in C57BL/6J mice positively modulated β-site amyloid precursor protein cleaving enzyme 1 (BACE1) activity, providing a potential future therapeutic strategy.Keywords
Funding Information
- ASC | Alzheimer Society Research Program
- Canadian Government | Canadian Institutes of Health Research (PJ9-166217)
- Canadian Government | Canadian Institutes of Health Research (PJT-169116)
- Canadian Government | Natural Sciences and Engineering Research Council of Canada (RGPIN-2017-03904)
This publication has 49 references indexed in Scilit:
- IDF Diabetes Atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045Diabetes Research and Clinical Practice, 2022
- Characterization of Alzheimer's disease‐like neuropathology in Duchenne's muscular dystrophy using the DBA/2J mdx mouse modelFEBS Open Bio, 2021
- A ketogenic drink improves cognition in mild cognitive impairment: Results of a 6‐month RCTAlzheimer's & Dementia, 2020
- Inflammation and insulin/IGF-1 resistance as the possible link between obesity and neurodegenerationJournal of Neuroimmunology, 2014
- The Pathobiology of Vascular DementiaNeuron, 2013
- An Overview of APP Processing Enzymes and ProductsNeuroMolecular Medicine, 2009
- Plasma BDNF is reduced among middle-aged and elderly women with impaired insulin function: Evidence of a compensatory mechanismBrain and Cognition, 2009
- Brain-derived neurotrophic factor (BDNF) and type 2 diabetesDiabetologia, 2006
- Profound and Selective Loss of Catalytic TrkB Immunoreactivity in Alzheimer's DiseaseBiochemical and Biophysical Research Communications, 1999
- BDNF mRNA is decreased in the hippocampus of individuals with Alzheimer's diseaseNeuron, 1991